i4KIDS Summer Party 2023 | Impact Investment in Pediatric Innovation
📑 How pediatric innovation is currently funded? It’s properly funded?
📅 14th June
⏲ From 16h30h to 20h00
- 16h30-17h00 · Welcome coffee
- 17h00-18h00 · Annual i4KIDS Assembly (language: catalan. Open to the whole ecosystem)
- 18h15-19h00 · Impact Investment in Pediatric Innovation · Marc Ramis, Venture Partner at Ship2B Ventures. (language: english), He will provide us with a roundup of philanthropic efforts and emerging venture capital firms focused on pediatric-first companies.
- 19h00-20h00 · Cocktail Networking
📍 Tech Barcelona Pier07 · Via Laietana 26, Barcelona & Online
About Marc Ramis · Venture Partner at Ship2B Ventures
Marc is passionate about launching ventures in the field of Children’s Health. Also, he brings more than 15 years of experience creating novel biomedical ventures. Recently, Marc was a co-founder & CEO at Rejuveron Senescence Therapeutics AG (Zürich), Ninevah Therapeutics Ltd (London) and Senolytic Therapeutics Inc (Boston). He is a Venture Partner at Ship2B Ventures. Marc also is a Board Member of multiple early-stage biotech companies such as Oniria Therapeutics SL, Gate2Brain SL or Nanobots Therapeutics SL. Marc gained a DPhil in Biochemistry from the University of Oxford in 2006, and a Harvard Business School PLD Program in 2011.